Product Description
Brand Mindray
Sample Type Serum
Pack Size 2 x 50T, 2 x 100T
CAT No 10500567000, 10500568700
Application Immuno-Assay
Ourchemiluminescence immunoassay reagentshave been specially developed to work with Mindray's CL series automatic chemiluminescence immunoassay analyzers to make a complete system, offering high reliability and accuracy. Mindray uses liquid, ready-to-use reagents which come in two packages, 50 tests and 100 tests, to suit customers with different requirements.
Advanced Tumor Marker DetectionMindray CYFRA 21-1 (CLIA) leverages state-of-the-art chemiluminescence immunoassay technology for reliable detection of CYFRA 21-1, a key biomarker for non-small cell lung cancer. The assay delivers accurate, sensitive, and reproducible results, supporting clinicians in timely diagnosis and monitoring therapeutic responses.
Compatibility and Ease of UseThe kit is specifically tailored for seamless integration with Mindray CL series analyzers, including the CL-1000i, CL-1200i, CL-2000i, and CL-6000i. Its ready-to-use liquid format streamlines workflow, eliminating preparation steps and minimizing the risk of errors for laboratory professionals.
Quality Assurance and Shelf LifeEach Mindray CYFRA 21-1 kit meets rigorous manufacturer accuracy standards, maintaining coefficient of variation (CV) below 10%. With a 10-month shelf life under recommended refrigerating conditions (2C-8C, not frozen), the reagents remain stable for consistent performance throughout their use period.
FAQ's of Mindray CYFRA 21-1 (CLIA):
Q: How is the Mindray CYFRA 21-1 (CLIA) kit used in medical laboratories?
A: Professional medical laboratory personnel use this kit with compatible Mindray CL series analyzers to quantitatively determine CYFRA 21-1 levels in human serum or plasma. The process is fully automated, requiring only the addition of patient samples to the ready-to-use reagents.
Q: What sample types are required for testing with this kit?
A: The Mindray CYFRA 21-1 (CLIA) kit is designed to analyze human serum or plasma samples for the detection and monitoring of CYFRA 21-1, a tumor marker associated with non-small cell lung cancer.
Q: When should the CYFRA 21-1 assay be utilized?
A: This assay is recommended for diagnostic laboratories when the detection or monitoring of non-small cell lung cancer is indicated. It can be used as part of diagnostic evaluation, prognosis assessment, or monitoring response to cancer therapy.
Q: Where can this reagent kit be integrated?
A: The kit is compatible exclusively with Mindray's CL-1000i, CL-1200i, CL-2000i, and CL-6000i chemiluminescence immunoassay analyzers in laboratory settings, ensuring efficient integration into established workflows.
Q: What are the storage requirements for the CYFRA 21-1 (CLIA) kit?
A: For optimal stability and accuracy, store the kit refrigerated between 2C and 8C. Do not freeze the reagents. This allows up to 10 months of shelf life from the date of manufacture.
Q: What are the main benefits of using the Mindray CYFRA 21-1 (CLIA) kit?
A: Benefits include high sensitivity (limit of detection: 0.5 ng/mL), a broad measurement range (0.5-100 ng/mL), high specificity, and automated operation. The kit supports reliable, real-time quantitative determination of CYFRA 21-1 levels to aid in cancer detection and management.
Q: Who are the intended users of this kit?
A: The Mindray CYFRA 21-1 (CLIA) kit is intended exclusively for use by trained professional medical laboratory personnel in certified diagnostic laboratory settings.